“A Change in Culture: A Review of the 2023 Infection Diseases Society of America (IDSA) Guidelines for the Treatment of Antimicrobial Resistant Gram-Negative Infections”
Event Navigation
HealthTrust presents…“A Change in Culture: A Review of the 2023 Infection Diseases Society of America (IDSA) Guidelines for the Treatment of Antimicrobial Resistant Gram-Negative Infections”
The rate of antibiotic resistance, particularly in Gram-negative organisms like Enterobacterales and P. aeruginosa, has emerged as a global crisis. The Centers for Disease Control & Prevention (CDC) reports that antimicrobial resistant organisms accounted for 2.8 million infections, causing 35,000 deaths between 2012 and 2017. Research with the newer antimicrobial agents is rapidly emerging, so it is vital that practitioners understand their appropriate place in therapy in order to use them effectively in the treatment of resistant Gram-negative organisms. The presenter will provide an overview of the updated IDSA guidelines regarding antimicrobial resistance among Gram-negative organisms, including a discussion of the relevance, incidence and epidemiology of antimicrobial resistance (AMR). A review the IDSA treatment recommendations and treatment rationale for the following: extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E), carbapenemresistant Enterobacterales (CRE), Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-PS) and carbapenemresistant Acinetobacter baumannii (CRAB) will also be discussed.
Learning Objectives for Pharmacists, Nurses & Lab Professionals | At the end of this session, participants should be able to:
- Recall the importance of antimicrobial resistance among Gram-negative organisms.
- Identify mechanisms of resistance, recommendations for treatment, and their rationale for highly resistant Gram-negative organisms.
- Recognize an appropriate antimicrobial regimen based on resistance patterns of a Gram-negative organism.
Presenter:
Cameron Crawford, PharmD | PGY-1 Pharmacy Resident | Princeton Baptist Medical Center | Birmingham, AL
Target Audience: Pharmacists, Nurses & Lab professionals
CE Credit: Approved for Pharmacists, Nurses & Lab professionals
This program is approved for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Number for this activity is 0863-9999-24-039-L01-P. The activity is approved for 1 hour (.1 CEUs) of continuing education credit for Pharmacists, Nurses and Lab professionals who attend the webinar and complete the online evaluation. Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.
Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.
